Outcomes of Treatment Using the ERMI Shoulder Flexionater ®

Outcomes of Treatment Using the ERMI Shoulder Flexionater®

Study 1 - Adhesive Capsulitis Study - 110 patients The purpose of this study is to compare treatment of patients with symptoms of adhesive capsulitis, primary and secondary, between three groups: I) Physical Therapy alone; II) ERMI Shoulder Flexionater® alone; III) PT + Device.

Study 2 - Postoperative Shoulder Stiffness Study - 90 patients The purpose of this study is to compare treatment of patients with post-operative stiffness indicative of secondary adhesive capsulitis between three groups: I) Physical Therapy alone; II) ERMI Shoulder Flexionater® alone; III) PT + Device.

Study 3 - Stiffness after MUA Study - enroll all eligible patients (goal of at least 15) The purpose of this study is to compare treatment of patients who have undergone manipulation under anesthesia or lysis of adhesions between three groups: I) Physical Therapy alone; II) ERMI Shoulder Flexionater® alone; III) PT + Device.

Study Overview

Status

Recruiting

Detailed Description

Study 1 - Adhesive Capsulitis Study (AC)

Objective: The purpose of this study is to compare treatment efficacy of patients with symptoms of primary and secondary adhesive capsulitis between three groups: 1) Patients treated with Physical Therapy alone; 2) Patients treated with the ERMI Shoulder Flexionater® alone; 3) Patients treated with PT + Device in the treatment.

  1. Prospective randomized control trial
  2. Sample size - 110 patients
  3. Study Groups:

    1. Group I - Physical Therapy Only
    2. Group II - Flexionater® only
    3. Group III - Flexionater® and Physical Therapy
  4. Length of study - 2-year follow-up from last enrolled patient

Study 2 - Postoperative Shoulder Stiffness Study (POS)

Objective: The purpose of this study is to compare treatment efficacy of patients with post-operative stiffness indicative of secondary adhesive capsulitis between three groups: I) Patients treated with Physical Therapy alone; II) Patients treated with the ERMI Shoulder Flexionater® alone; III) Patients treated with PT + Device in the treatment.

  1. Prospective randomized control trial
  2. Sample size - 90 enrolled patients
  3. Study Groups:

    1. Group I - Physical Therapy only
    2. Group II - Flexionater® only
    3. Group III - Flexionater® and Physical Therapy
  4. Length of study - 2-year follow-up from last enrolled patient

Study 3 - Secondary Surgery Study (SAM)

Objective: The purpose of this study is to compare recovery of patients who have undergone a manipulation under anesthesia or a lysis of adhesions between three groups: 1) Patients treated with Physical Therapy alone; 2) Patients treated with the ERMI Shoulder Flexionater® alone; 3) Patients treated with PT + Device in the treatment.

  1. Prospective randomized control trial
  2. Sample size - 10 enrolled patients
  3. Study Groups:

    1. Group I Physical Therapy Only
    2. Group II - - Flexionater® only
    3. Group III - Flexionater® and Physical Therapy
  4. Length of study - 2-year follow-up from last enrolled patient

Study Type

Interventional

Enrollment (Estimated)

210

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Florida
      • Tampa, Florida, United States, 33607
        • Recruiting
        • Foundation for Orthopaedic Research and Education
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

For Study Group 1- Adhesive Capsulitis (AC)

Inclusion Criteria:

  • Exhibits symptoms of adhesive capsulitis i. Shoulder pain with limited motion for more than one month ii. AND ≤ 30 degrees external rotation with arm at side iii. AND ≤ 130 degrees forward flexion d. Cortisone shot for all patients

Exclusion Criteria:

  • a. No prior shoulder surgery b. Infection c. Rheumatoid arthritis d. Any structural or systemic disorder that could result in pain or ROM limitation i. Such as inflammatory joint disease, osteoarthritis evidenced on radiographs ii. full thickness rotator cuff tear as shown by ultrasound imaging iii. history of major trauma or surgery involving the shoulder

For Study Group 2 - Postoperative Shoulder Stiffness Study (POS)

Inclusion Criteria:

c. Is not recovering normally based on objective criteria set for screening process i. Step 1 - Follow patients -all post-op patients with indicated procedures (see # 7 for list.) ii. Step 2 - Screen Patients -does patient meets inclusion criteria at 6 weeks or 3 months of follow-up?

  1. < 15 degrees external rotation with arm at side at 6 weeks post-op
  2. OR < 90 degrees forward flexion at 3 months post-op iii. Step 3 - Enroll patients that meet inclusion criteria and assign group

Exclusion Criteria:

a. Revision surgery b. Infection c. Rheumatoid arthritis

7. Procedures included

  1. Shoulder arthroscopic procedures (29827, 29828, 29823,29824, 29826)
  2. ORIF Humerus fracture (23615)

    For Study Group 3, Secondary Surgery Study (SAM)

    Inclusion Criteria:

  3. Underwent a manipulation under anesthesia or a lysis of adhesions procedure

Exclusion Criteria:

a. Infection b. Rheumatoid arthritis c. Any structural or systemic disorder that could result in pain or ROM limitation i. Such as inflammatory joint disease, osteoarthritis evidenced on radiographs ii. full thickness rotator cuff tear as shown by ultrasound imaging iii. history of major trauma or surgery involving the shoulder

7. Procedures included

  1. Manipulation under anesthesia (23700)
  2. Lysis of adhesions (29825)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Adhesive Capsulitis Study
The purpose of this study is to compare treatment efficacy of patients with symptoms of primary and secondary adhesive capsulitis between three groups: 1) Patients treated with Physical Therapy alone; 2) Patients treated with the ERMI Shoulder Flexionater® alone; 3) Patients treated with PT + Device in the treatment.
High Intensity Stretch and Physical Therapy are used either together or alone to treat study arm.
Other Names:
  • Physical Therapy
Active Comparator: Post operative Shoulder Stiffness Study
The purpose of this study is to compare treatment efficacy of patients with post-operative stiffness indicative of secondary adhesive capsulitis between three groups: I) Patients treated with Physical Therapy alone; II) Patients treated with the ERMI Shoulder Flexionater® alone; III) Patients treated with PT + Device in the treatment.
High Intensity Stretch and Physical Therapy are used either together or alone to treat study arm.
Other Names:
  • Physical Therapy
Active Comparator: Secondary Surgery Study
The purpose of this study is to compare recovery of patients who have undergone a manipulation under anesthesia or a lysis of adhesions between three groups: 1) Patients treated with Physical Therapy alone; 2) Patients treated with the ERMI Shoulder Flexionater® alone; 3) Patients treated with PT + Device in the treatment.
High Intensity Stretch and Physical Therapy are used either together or alone to treat study arm.
Other Names:
  • Physical Therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Shoulder Range of Motion Improvement
Time Frame: 3 months
Measuring Shoulder External Rotation and Forward Flexion using a goniometer according to standard practice
3 months
Shoulder Range of Motion
Time Frame: 6 months
Measuring Shoulder External Rotation and Forward Flexion using a goniometer according to standard practice
6 months
Shoulder Range of Motion
Time Frame: 12 months
Measuring Shoulder External Rotation and Forward Flexion using a goniometer according to standard practice
12 months
Shoulder Range of Motion
Time Frame: 24 months
Measuring Shoulder External Rotation and Forward Flexion using a goniometer according to standard practice
24 months
Shoulder Range of Motion
Time Frame: 6 weeks
Measuring Shoulder External Rotation and Forward Flexion using a goniometer according to standard practice
6 weeks
Shoulder Range of Motion
Time Frame: baseline
Measuring Shoulder External Rotation and Forward Flexion using a goniometer according to standard practice
baseline
VAS (Visual Analog Scale) Pain Score
Time Frame: 3 months
Visual Analog Scale Pain Score 0 (no pain) - 10 (pain as bad as it can be)
3 months
VAS Pain Score
Time Frame: 6 weeks
Visual Analog Scale Pain Score: 0 (no pain) - 10 (pain as bad as it can be)
6 weeks
VAS Pain Score
Time Frame: 6 months
Visual Analog Scale Pain Score: 0 (no pain) - 10 (pain as bad as it can be)
6 months
VAS Pain Score
Time Frame: 12 months
Visual Analog Scale Pain Score: 0 (no pain) - 10 (pain as bad as it can be)
12 months
VAS Pain Score
Time Frame: 24 months
Visual Analog Scale Pain Score: 0 (no pain) - 10 (pain as bad as it can be)
24 months
VAS Pain Score
Time Frame: baseline
Visual Analog Scale Pain Score: 0 (no pain) - 10 (pain as bad as it can be)
baseline
ASES Score
Time Frame: baseline
American Shoulder and Elbow Society Score (10 activities of daily living are calculated)
baseline
ASES Score
Time Frame: 3 month
American Shoulder and Elbow Society Score (10 activities of daily living are calculated)
3 month
ASES Score
Time Frame: 6 weeks
American Shoulder and Elbow Society Score (10 activities of daily living are calculated)
6 weeks
ASES Score
Time Frame: 6 months
American Shoulder and Elbow Society Score (10 activities of daily living are calculated)
6 months
ASES Score
Time Frame: 12 months
American Shoulder and Elbow Society Score (10 activities of daily living are calculated)
12 months
ASES Score
Time Frame: 24 months
American Shoulder and Elbow Society Score (10 activities of daily living are calculated)
24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SST
Time Frame: Baseline
Simple Shoulder Test
Baseline
SST
Time Frame: 3 month
Simple Shoulder Test
3 month
SST
Time Frame: 6 weeks
Simple Shoulder Test
6 weeks
SST
Time Frame: 6 months
Simple Shoulder Test
6 months
SST
Time Frame: 12 months
Simple Shoulder Test
12 months
SST
Time Frame: 24 months
Simple Shoulder Test
24 months
Device Compliance Questionnaire (if applicable)
Time Frame: 6 weeks
compliance with Device usage
6 weeks
Device Compliance Questionnaire (if applicable)
Time Frame: 3 months
compliance with Device usage
3 months
Device Compliance Questionnaire (if applicable)
Time Frame: 6 months
compliance with Device usage
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Director: Peter Simon, PhD, Foundation for Orthopaedic Research and Education

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 25, 2019

Primary Completion (Estimated)

October 25, 2025

Study Completion (Estimated)

June 25, 2026

Study Registration Dates

First Submitted

May 3, 2022

First Submitted That Met QC Criteria

May 17, 2022

First Posted (Actual)

May 20, 2022

Study Record Updates

Last Update Posted (Actual)

August 7, 2025

Last Update Submitted That Met QC Criteria

August 4, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • FORE AC 2019

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

unknown at this time

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adhesive Capsulitis of Shoulder

Clinical Trials on High Intensity Stretch Device

Subscribe